Liquid Biopsies and Cancer Immunotherapy

被引：18
作者：
Thompson, Jonathan R. [1 ]
Menon, Smitha P. [1 ]
机构：
[1] Med Coll Wisconsin, Dept Med, Div Hematol & Oncol, Milwaukee, WI 53226 USA
来源：
CANCER JOURNAL | 2018年 / 24卷 / 02期
关键词：
Immunotherapy; tumor microenvironment; immune checkpoint inhibitor; tumor mutation burden; CIRCULATING TUMOR DNA; PROGRESSION-FREE SURVIVAL; DROPLET DIGITAL PCR; REGULATORY T-CELLS; PD-1; BLOCKADE; PERIPHERAL-BLOOD; INDUCE APOPTOSIS; OPEN-LABEL; NIVOLUMAB; PEMBROLIZUMAB;
D O I：
10.1097/PPO.0000000000000307
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Cancer immunotherapy has recently undergone rapid advances and has become an integral part of the treatment armamentarium in various malignancies. However, tissue-based biomarker development in this arena has been slow, and valid biomarker identification to guide immunotherapeutic management is desperately needed. "Liquid" or blood-based biopsies potentially offer more convenient and efficient means to judge the immune milieu of individual patients and identify who will benefit most from immunotherapy. The following review highlights the current literature regarding the application of liquid biopsies to cancer immunotherapy.
引用
收藏
页码：78 / 83
页数：6
相关论文
共 50 条
  • [31] Immunotherapy in Head and Neck Cancer: Where Do We Stand?
    Vallianou, Natalia G.
    Evangelopoulos, Angelos
    Kounatidis, Dimitris
    Panagopoulos, Fotis
    Geladari, Eleni
    Karampela, Irene
    Stratigou, Theodora
    Dalamaga, Maria
    CURRENT ONCOLOGY REPORTS, 2023, 25 (08) : 897 - 912
  • [32] Liquid Biopsies in Lung Cancer
    Kemper, Marcel
    Krekeler, Carolin
    Menck, Kerstin
    Lenz, Georg
    Evers, Georg
    Schulze, Arik Bernard
    Bleckmann, Annalen
    CANCERS, 2023, 15 (05)
  • [33] Liquid Biopsies in Lung Cancer
    Tsao, M.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S195 - S196
  • [34] The role of immunotherapy sensitizers and novel immunotherapy modalities in the treatment of cancer
    Correia, Guilherme Sacchi de Camargo
    Zhao, Yujie
    Manochakian, Rami
    Lou, Yanyan
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [35] Role of immunotherapy in kidney cancer
    Nazzani, Sebastiano
    Bazinet, Amelie
    Karakiewicz, Pierre I.
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2018, 12 (03) : 325 - 333
  • [36] New Immunotherapy and Lung Cancer
    de Cos Escuin, Julio Sanchez
    ARCHIVOS DE BRONCONEUMOLOGIA, 2017, 53 (12): : 682 - 687
  • [37] Advances in Immunotherapy in Esophagogastric Cancer
    Jazieh, Khalid
    Yoon, Harry
    Zhu, Mojun
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2024, 38 (03) : 599 - 616
  • [38] Acquired resistance to cancer immunotherapy
    Draghi, Arianna
    Chamberlain, Christopher Aled
    Furness, Andrew
    Donia, Marco
    SEMINARS IN IMMUNOPATHOLOGY, 2019, 41 (01) : 31 - 40
  • [39] Immunotherapy for older patients with cancer
    Araujo Vargas, Tatianny P.
    Al-Humiqani, Abdullah
    Mata, Danilo Giffoni De Mello Morais
    Menjak, Ines B.
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2023, 17 (01) : 37 - 46
  • [40] Progresses in biomarkers for cancer immunotherapy
    Lin, Xuwen
    Zong, Chenyu
    Zhang, Zhihan
    Fang, Weiyi
    Xu, Ping
    MEDCOMM, 2023, 4 (05):
12345